|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$1.21 |
$1.24 |
$1.18 |
$1.20 |
3.75M | 04/15/2024 |
$1.19 |
$1.19 |
$1.14 |
$1.15 |
768.50K | 04/16/2024 |
$1.14 |
$1.16 |
$1.10 |
$1.14 |
754.90K | 04/17/2024 |
$1.14 |
$1.16 |
$1.11 |
$1.11 |
578.00K | 04/18/2024 |
$1.12 |
$1.12 |
$1.05 |
$1.05 |
1.24M |
|
Rigel Pharmaceuticals is a biotechnology company focused on discovering, developing and providing small molecule drugs that improve the lives of patients with hematologic disorders, cancer and rare immune diseases. Co.'s U.S. Food and Drug Administration approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, an oral spleen tyrosine kinase inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The product is also commercially available in Europe, the U.K. (TAVLESSE) and Canada (TAVALISSE) for the treatment of chronic immune thrombocytopenia in adult patients. | |
|
Rigel Pharmaceuticals (RIGL) has the following price history information. Looking back at RIGL historical stock prices for the last five trading days, on April 12, 2024, RIGL opened at $1.21, traded as high as $1.24 and as low as $1.18, and closed at $1.20. Trading volume was a total of 3.75M shares. On April 15, 2024, RIGL opened at $1.19, traded as high as $1.19 and as low as $1.14, and closed at $1.15. Trading volume was a total of 768.50K shares. On April 16, 2024, RIGL opened at $1.14, traded as high as $1.16 and as low as $1.10, and closed at $1.14. Trading volume was a total of 754.90K shares. On April 17, 2024, RIGL opened at $1.14, traded as high as $1.16 and as low as $1.11, and closed at $1.11. Trading volume was a total of 578.00K shares. On April 18, 2024, RIGL opened at $1.12, traded as high as $1.12 and as low as $1.05, and closed at $1.05. Trading volume was a total of 1.24M shares.
RIGL Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Rigel Pharmaceuticals shares, starting with a $10,000 purchase of RIGL, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$3.42 |
|
End price/share: |
$1.05 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-69.30% |
|
Average Annual Total Return: |
-11.14% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,070.46 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $1.20 | 04/15/2024 | $1.15 | 04/16/2024 | $1.14 | 04/17/2024 | $1.11 | 04/18/2024 | $1.05 |
|
|